Natural History of Autosomal Dominant Hearing Loss
NCT04501081
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Background: Hereditary hearing loss is one of the most common sensory disabilities affecting newborns. The main options for people with hereditary hearing loss are hearing aids and cochlear implants. Both options have their limitations and do not restore biological hearing. Researchers want to learn if gene editing might be a treatment option. Objective: To understand the genes that cause non-syndromic autosomal dominant hearing loss (DFNA) in people with DFNA as well as their family members.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Hearing Loss
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 3 to 99 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Last updated on ClinicalTrials.gov
- July 23, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- National Institutes of Health Clinical Center · Bethesda, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.